Not applicableEnded earlyNCT04773275What this trial is testingA Clinical Evaluation of the Aliya™ System in Late Stage CancerWho this might be right forCancer of Lung, Kidney or Liver Galvanize Therapeutics, Inc. 4
Early research (Phase 1)Study completedNCT02387307What this trial is testingRSIFN-co in Subjects With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more Sichuan Huiyang Life Science and Technology Corporation 42
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Early research (Phase 1)Looking for participantsNCT06582017What this trial is testingSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaWho this might be right forOvarian CancerPancreas CancerUrothelial Carcinoma+6 more Nammi Therapeutics Inc 100
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableStudy completedNCT02921828What this trial is testingA Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mgWho this might be right forMultiple Myeloma Celgene 1,149
Not applicableEnded earlyNCT02900248What this trial is testingCureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceWho this might be right forNeoplasmsLung NeoplasmsColon Neoplasms+22 more CureOne 23
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Not applicableUnknownNCT05635266What this trial is testingTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesWho this might be right forAge-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more Sanguine Biosciences 20,000
Early research (Phase 1)Active Not RecruitingNCT01366144What this trial is testingVeliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWho this might be right forBreast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT02859415What this trial is testingContinuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary MetastasesWho this might be right forEsophageal NeoplasmsLung NeoplasmsMesothelioma+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT03755739What this trial is testingTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsWho this might be right forHepatocarcinomaLung CancerMelanoma+7 more Second Affiliated Hospital of Guangzhou Medical University 200